BioPharma Credit PLC (BPCR) — Cash Flow Reinvestment Rate
BioPharma Credit PLC (BPCR) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $33.76 Million. Check earnings quality score of BioPharma Credit PLC to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
BioPharma Credit PLC Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for BioPharma Credit PLC across 8 annual periods. Explore BioPharma Credit PLC strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for BioPharma Credit PLC (2017–2024)
Year-by-year capital reinvestment analysis for BioPharma Credit PLC. For live market cap and broader valuation context, see BPCR market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.35x | $39.07 Million | $111.91 Million | $0.00 | ▲ +2497.0% |
| 2023 | 0.01x | $1.66 Million | $123.18 Million | $0.00 | ▼ -94.9% |
| 2022 | 0.26x | $48.19 Million | $184.28 Million | $0.00 | ▼ -73.4% |
| 2021 | 0.98x | $94.82 Million | $96.44 Million | $0.00 | ▲ +20.3% |
| 2020 | 0.82x | $47.47 Million | $58.07 Million | $0.00 | ▲ +7.2% |
| 2019 | 0.76x | $100.30 Million | $131.52 Million | $0.00 | ▼ -88.3% |
| 2018 | 6.51x | $436.99 Million | $67.14 Million | $0.00 | ▼ -57.7% |
| 2017 | 15.38x | $354.74 Million | $23.07 Million | $0.00 | — |